139
Views
8
CrossRef citations to date
0
Altmetric
Research articles

Willingness to participate in future HIV prevention trials in Beira, Mozambique

, , , , , , & show all

References

  • Buchbinder SP, Metch BM, Holte SE, Scheer S, Coletti A, Vittinghoff E. 2004. Determinants of enrollment in a preventive HIV vaccine trail. Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes 36: 604–612.
  • de Bruyn G, Skhosana N, Robertson G, McIntyre JA, Gray GE. 2008. Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Research Notes 1: 76, doi: 10.1186/1756-0500-1-76.
  • Dubé K, Zango A, van de Wijgert JH, Meque I, Ferro JJ, Cumbe F, Chen PL, Ma S, Jolles E, Fumo A, Robb ML, Feldblum PJ. 2014. HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009–2012. PLoS One 9: e84979.
  • González R, Munguambe K, Aponte J, Bavo C, Nhalungo D, Macete E, Alonso P, Menéndez C, Naniche D. 2012. High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey. HIV Medicine 13: 581–588.
  • Halpern SD, Metzeger DS, Berlin JA, Ubel PA. 2001. Who will enrol? Predicting participation in a Phase II AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndromes 27: 281–288.
  • INS (Instituto Nacional de SaúdeS), INE (InstitutoNacional de Estatística), ICF Macro. 2010. InquéritoNacional de Prevalência, RiscosComportamentais e informaçãosobre HIV e SIDA emMoçambique 2009. Calverton, Maryland: EUA: INS, INE and ICF Macro.
  • Jaspan HB, Flisher AJ, Meyer L, Matthews C, Middelkoop K, Mark D, Bekker L-G. 2011. Sexual health, HIV risk, and retention in an adolescent HIV-prevention trial preparatory cohort. Journal of Adolescent Health 49: 42–46.
  • Jenkins RA, Torugsa K, Markowitz LE, Mason CJ, Jamroentana V, Brown AE, Nitayaphan S. 2000. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections 76: 386–392.
  • Middelkoop K, Myer L, Mark D, Mthimunyea SP, Smit J, Wood R, Bekker L-G. 2008. Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. Journal of Adolescent Health 43: 8–14.
  • Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, Sulway C, Wilson K. 2004 Barriers to participate in an HIV vaccine trial: a systematic review. AIDS 18: 2235–2242.
  • Newman PA, Duan N, Roberts K, Seiden D, Rudy ET, Swendeman D, Popova S. 2006. HIV vaccine trial participation among ethnic minority communities. Barriers, motivators, and implications for recruitment. Journal of Acquired Immune Deficiency Syndromes 41: 210–217.
  • Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, Khanani F, Emrick CB, MacQueen K. 2001. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes 26: 63–71.
  • Tarimo EAM, Thorson A, Bakari M, Mwami J, Sandström E, Kulane A. 2009. Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. Global Health Action 2, doi:10.3402/gha.v2i0.1953.
  • UNAIDS (Joint United Nations Programme on HIV/AIDS). 2012 UNAIDS report on the global AIDS epidemic. 2012. Available at http://www.unaids.org/en/resources/publications/2012/name,76121,en.asp [accessed 9 August 2013].
  • van der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, von Mollendorf C, Bekker L, Ganesh S, Young K, Romano J, Nel A, Woodsong C. 2012. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS and Behavior 16: 1775–1786.
  • Zango A, Dubé K, Kelbert S, Meque I, Cumbe F, Chen PL, Ferro JJ, Feldblum PJ, van de Wijgert J. 2013. Determinants of prevalent HIV infection and late HIV diagnosis among young women with two or more sexual partners in Beira, Mozambique. PLoS One 8: e63427.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.